Pediatric Hematology/Oncology

Non-Hodgkin Lymphoma   

Questions discussed in this category



How would the risk of VTE associated with crizotinib affect your decision? Should we consider using crizotinib in combination with brentuximab?

Is an LP only recommended in the setting of particular subtypes of lymphoma or symptoms of CNS disease?

NCCN guideline V4.2021 DLBCL page BCEL-3 states stage I-II, bulky >= 7.5cm should be treated with 6 cycles of RCHOP, but most bone lymphoma studies...

Do you prefer a cHL chemotherapy backbone or PMBL chemotherapy backbone?

What if the patient has a history of confirmed COVID-19 but has since recovered?


Papers discussed in this category


J Clin Oncol, 2019 Oct 14

Blood, 2021 Mar 08

Cancer chemotherapy and pharmacology, 2017-01

British journal of haematology, 2008-06

Leukemia, 2021 May 03

N Engl J Med,

J Clin Oncol, 2022 Dec 19

N Engl J Med,